Annual income statement for Livero, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,377 | 2,555 | 2,901 | 3,587 | 4,364 |
| Cost of Revenue | |||||
| Gross Profit | 2,050 | 2,225 | 2,460 | 2,854 | 3,136 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,017 | 2,477 | 2,762 | 3,131 | 3,604 |
| Operating Profit | 360 | 77.9 | 139 | 455 | 760 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 346 | 78 | 140 | 474 | 765 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 239 | 50.8 | 104 | 339 | 532 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 239 | 50.8 | 104 | 339 | 532 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 239 | 50.8 | 104 | 339 | 532 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 45.1 | 8.74 | 23.7 | 59.1 | 90.8 |
| Dividends per Share | |||||
| Special Dividends per Share |